Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

SML3707

Sigma-Aldrich

Prulifloxacin

≥98% (HPLC)

Synonym(s):

(±)-7-[4-[(Z)-2,3-Dihydroxy-2-butenyl]-1-piperazinyl]-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid cyclic carbonate, 6-Fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid, NM 441, NM441

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C21H20FN3O6S
CAS Number:
123447-62-1
Molecular Weight:
461.46
MDL number:
MFCD00864847
UNSPSC Code:
12352200
NACRES:
NA.77
Pricing and availability is not currently available.

Quality Level

100

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear (Warmed)

storage temp.

-10 to -25°C

SMILES string

Fc1cc2c(cc1N4CCN(CC4)CC5=C(OC(=O)O5)C)N3C(SC3=C(C2=O)C(=O)O)C

InChI

1S/C21H20FN3O6S/c1-10-16(31-21(29)30-10)9-23-3-5-24(6-4-23)15-8-14-12(7-13(15)22)18(26)17(20(27)28)19-25(14)11(2)32-19/h7-8,11H,3-6,9H2,1-2H3,(H,27,28)

InChI key

PWNMXPDKBYZCOO-UHFFFAOYSA-N

Biochem/physiol Actions

Broad spectrum antibiotic that potently inhibits bacterial DNA gyrase and topoisomerase IV
Prulifloxacin is a synthetic fluoroquinolone broad spectrum antibiotic that potently inhibits bacterial DNA gyrase and topoisomerase IV.

Pictograms

Health hazardExclamation mark
GHS08,GHS07

Signal Word

Warning

Hazard Statements

H315,H362,H373

Hazard Classifications

Lact. - Skin Irrit. 2 - STOT RE 2

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000241011
0000241010
0000237188
0000241011
0000241010

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

M Ozaki et al.
Antimicrobial agents and chemotherapy, 35(12), 2496-2499 (1991-12-01)
NM441 is a lipophilic prodrug of a new thiazeto-quinoline carboxylic acid derivative NM394, and when it is administered orally it is readily absorbed and hydrolyzed to its parent compound. After oral administration of NM441 at a dose of 20 mg/kg
Gabriele Tulone et al.
Antibiotics (Basel, Switzerland), 11(3) (2022-03-26)
Our study aimed to compare the incidence of infective complications after transrectal ultrasound-guided prostate biopsy (TRUSBx) when adopting different antimicrobial prophylaxis regimens. A multi-institutional cohort of 1150 patients who underwent TRUSBx was retrospectively analyzed. Procedures were performed between 2017 and
Maria Gabriella Matera
Pulmonary pharmacology & therapeutics, 19 Suppl 1, 20-29 (2005-12-20)
Prulifloxacin, the prodrug of ulifloxacin, is a broad-spectrum oral fluoroquinolone antibacterial agent. After absorption, prulifloxacin is metabolized by esterases to ulifloxacin. The drug has a long elimination half-life, allowing once-daily administration. In vitro, ulifloxacin is generally more active than other

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service